Lifestyle Physical Activity for HIV/AIDS and Problem Drinking
Trial Summary
What is the purpose of this trial?
This trial tests if increasing physical activity using a Fitbit can help people with HIV who drink too much. One group gets extra help to be more active, while the other just uses the Fitbit. The goal is to see if being more active can reduce drinking and improve health. Fitbit devices have been widely used in various studies to promote physical activity and have shown effectiveness in increasing activity levels and improving health outcomes.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, you must be able to confirm your HIV diagnosis through visual evidence of ART medication or medical record, suggesting that continuing ART is expected.
What data supports the effectiveness of the treatment Fitbit-Based Physical Activity Intervention for people with HIV/AIDS and problem drinking?
Research suggests that regular physical activity can provide health benefits for people living with HIV/AIDS, similar to those seen in the general population. However, a study found that using a Fitbit with walk step reminders did not significantly improve physical activity levels in people with HIV, indicating that additional tailored interventions may be necessary.12345
Is using a Fitbit or similar device safe for people with HIV/AIDS?
How is the Lifestyle Physical Activity treatment for HIV/AIDS and problem drinking different from other treatments?
This treatment is unique because it uses a Fitbit to encourage physical activity, which is not a standard approach for managing HIV/AIDS and problem drinking. It focuses on increasing physical activity through wearable technology and lifestyle sessions, rather than traditional medication or therapy.13459
Research Team
Michael D Stein, MD
Principal Investigator
Boston University, School of Public Health - Health Law Policy & Management
Lisa Quintiliani, PhD
Principal Investigator
Tufts Medical Center
Eligibility Criteria
This trial is for adults in the USA living with HIV and engaging in unhealthy drinking, which means more than 7 drinks per week for women or more than 14 for men. Participants should be less active than recommended (under 150 minutes of moderate exercise weekly), own a smartphone, can prove their HIV status, and have a U.S. mailing address. It's not for those with certain mental health conditions, eating disorders, severe medical issues preventing safe exercise, or those currently treated non-pharmacologically for alcohol use.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are assigned to either the LPA or Fitbit Only intervention for 12 weeks. The LPA arm receives 7 sessions with a trained interventionist, while the Fitbit Only arm receives brief check-in calls.
Follow-up
Participants are monitored for changes in physical activity and drinking outcomes at 3 and 6 months post-treatment.
Treatment Details
Interventions
- Fitbit (Other)
- Fitbit Only (Other)
- LPA Sessions (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Boston University
Lead Sponsor
Sophie Kornowski
Boston University
Chief Executive Officer since 2022
MBA from the University of Chicago, Doctorate in Pharmacy from Paris Descartes University
Dr. Patrizia Cavazzoni
Boston University
Chief Medical Officer
MD from McGill University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Collaborator
Dr. George F. Koob
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Chief Executive Officer since 2014
PhD in Neurobiology from the Scripps Research Institute
Dr. Patricia Powell
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Chief Medical Officer since 2015
MD from an accredited institution